Esther Rajavelu
Stock Analyst at UBS
(0.67)
# 3,797
Out of 4,835 analysts
28
Total ratings
43.75%
Success rate
-24.64%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Esther Rajavelu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $331 → $349 | $283.40 | +23.15% | 6 | May 2, 2025 | |
| APLT Applied Therapeutics | Downgrades: Neutral | $13 → $2 | $0.49 | +307.41% | 3 | Dec 2, 2024 | |
| DNLI Denali Therapeutics | Maintains: Buy | $70 → $32 | $14.16 | +125.99% | 2 | Apr 9, 2024 | |
| RARE Ultragenyx Pharmaceutical | Initiates: Sell | $73 | $34.84 | +109.53% | 1 | Aug 19, 2021 | |
| BHVN Biohaven | Downgrades: Neutral | $108 → $109 | $15.82 | +589.00% | 6 | Aug 10, 2021 | |
| STOK Stoke Therapeutics | Initiates: Neutral | $35 | $9.63 | +263.45% | 1 | May 18, 2021 | |
| IONS Ionis Pharmaceuticals | Upgrades: Neutral | $33 → $38 | $32.99 | +13.67% | 3 | May 7, 2021 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $174 → $228 | $106.07 | +114.95% | 1 | Mar 1, 2021 | |
| EYEN Eyenovia | Downgrades: Perform | n/a | $1.13 | - | 2 | Feb 3, 2020 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Perform | n/a | $15.34 | - | 1 | Dec 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $13 | $18.30 | -28.94% | 1 | Nov 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.46 | +584.93% | 1 | Jul 21, 2017 |
Alnylam Pharmaceuticals
May 2, 2025
Maintains: Buy
Price Target: $331 → $349
Current: $283.40
Upside: +23.15%
Applied Therapeutics
Dec 2, 2024
Downgrades: Neutral
Price Target: $13 → $2
Current: $0.49
Upside: +307.41%
Denali Therapeutics
Apr 9, 2024
Maintains: Buy
Price Target: $70 → $32
Current: $14.16
Upside: +125.99%
Ultragenyx Pharmaceutical
Aug 19, 2021
Initiates: Sell
Price Target: $73
Current: $34.84
Upside: +109.53%
Biohaven
Aug 10, 2021
Downgrades: Neutral
Price Target: $108 → $109
Current: $15.82
Upside: +589.00%
Stoke Therapeutics
May 18, 2021
Initiates: Neutral
Price Target: $35
Current: $9.63
Upside: +263.45%
Ionis Pharmaceuticals
May 7, 2021
Upgrades: Neutral
Price Target: $33 → $38
Current: $32.99
Upside: +13.67%
Jazz Pharmaceuticals
Mar 1, 2021
Maintains: Buy
Price Target: $174 → $228
Current: $106.07
Upside: +114.95%
Eyenovia
Feb 3, 2020
Downgrades: Perform
Price Target: n/a
Current: $1.13
Upside: -
Arrowhead Pharmaceuticals
Dec 13, 2019
Initiates: Perform
Price Target: n/a
Current: $15.34
Upside: -
Nov 20, 2017
Initiates: Hold
Price Target: $13
Current: $18.30
Upside: -28.94%
Jul 21, 2017
Initiates: Buy
Price Target: $10
Current: $1.46
Upside: +584.93%